Regulus Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Regulus Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Regulus Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 65.5M shares, a 224% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 65.5M +45.3M +224% Nov 1, 2024 10-Q 2024-11-07
Q2 2024 65.5M +46M +236% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 65.5M +48.6M +289% Mar 15, 2024 10-K 2024-03-21
Q3 2023 20.2M +3.38M +20.1% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 19.5M +4.85M +33.1% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 16.8M -129M -88.5% Mar 17, 2023 10-K 2023-03-23
Q3 2022 16.8M -70.2M -80.7% Nov 4, 2022 10-Q 2022-11-14
Q2 2022 14.6M -72.4M -83.2% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 146M +73.5M +101% Mar 4, 2022 10-K 2022-03-11
Q3 2021 87M +47.9M +122% Nov 5, 2021 10-Q 2021-11-12
Q2 2021 87M +51.1M +142% Aug 6, 2021 10-Q 2021-08-10
Q1 2021 72.5M +51.5M +245% Mar 5, 2021 10-K 2021-03-09
Q3 2020 39.2M +18.2M +87.1% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 35.9M +15.1M +72.5% Aug 7, 2020 10-Q 2020-08-13
Q1 2020 21M +10.3M +95.8% Mar 6, 2020 10-K 2020-03-12
Q3 2019 20.9M +12.2M +139% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 20.8M -84M -80.1% Aug 2, 2019 10-Q 2019-08-08
Q1 2019 10.7M -93.6M -89.7% Mar 8, 2019 10-K 2019-03-18
Q3 2018 8.75M -95.2M -91.6% Nov 2, 2018 10-Q 2018-11-09
Q2 2018 105M +1.01M +0.98% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 104M +51.1M +96.2% May 4, 2018 10-Q 2018-05-10
Q3 2017 104M +51M +96.4% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 104M +51M +96.5% Jul 28, 2017 10-Q 2017-08-02
Q1 2017 53.2M +401K +0.76% Apr 28, 2017 10-Q 2017-05-05
Q3 2016 52.9M +581K +1.11% Oct 28, 2016 10-Q 2016-11-02
Q2 2016 52.8M +901K +1.74% Jul 29, 2016 10-Q 2016-08-03
Q1 2016 52.8M +1.76M +3.46% Apr 27, 2016 10-Q 2016-05-03
Q3 2015 52.3M +3.74M +7.69% Oct 30, 2015 10-Q 2015-11-06
Q2 2015 51.9M +8.53M +19.7% Jul 24, 2015 10-Q 2015-08-05
Q1 2015 51M +7.66M +17.7% Apr 24, 2015 10-Q 2015-05-08
Q4 2014 50.5M +7.35M +17% Feb 6, 2015 10-K 2015-02-19
Q3 2014 48.6M +6.83M +16.3% Nov 3, 2014 10-Q 2014-11-06
Q2 2014 43.4M +2.06M +4.99% Jul 25, 2014 10-Q 2014-08-07
Q1 2014 43.4M +7.35M +20.4% Apr 25, 2014 10-Q 2014-05-09
Q4 2013 43.2M +7.28M +20.3% Feb 7, 2014 10-K 2014-02-28
Q3 2013 41.8M Nov 8, 2013 10-Q 2013-11-14
Q2 2013 41.3M Aug 12, 2013 10-Q/A 2013-08-16
Q1 2013 36M May 10, 2013 10-Q 2013-05-15
Q4 2012 35.9M Feb 14, 2013 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.